Stamps Alasdair C, Terrett Jonathan A, Adam Paul J
Oxford GlycoSciences (UK) Ltd, The Form, 86 Milton Park, Abingdon, UK OX14 4RY.
J Nanobiotechnology. 2003 May 28;1(1):3. doi: 10.1186/1477-3155-1-3.
Detection of disease-associated gene transcripts in primary disease tissues is frequently confounded by the presence of non-involved cell types. Alternative methods of detecting gene expression directly within tissues involve either the generation of antibodies, which can be a lengthy process and may suffer from lack of specificity, or amplification of reverse-transcribed cDNA in tissue sections (in situ RT-PCR). The latter method is highly specific and enables detection of transcripts in the cells originally responsible for their synthesis, but is highly destructive of tissue structures and can be carried out on only one or a few sections per experiment, resulting in low reproducibility. In this study, in situ RT-PCR was applied for the first time to commercially available tissue section microarrays enabling the examination of up to 70 different samples simultaneously. Modifications to the technique are detailed that preserved visible tissue and cellular structures and improved transcript detection whilst preventing significant generation of artefacts.
在原发性疾病组织中检测与疾病相关的基因转录本常常因存在未受累的细胞类型而受到干扰。直接在组织内检测基因表达的其他方法,要么是生成抗体,这可能是一个漫长的过程,且可能缺乏特异性;要么是在组织切片中扩增逆转录的cDNA(原位逆转录聚合酶链反应)。后一种方法具有高度特异性,能够在最初负责合成转录本的细胞中检测到转录本,但对组织结构具有高度破坏性,且每个实验只能在一个或几个切片上进行,导致重现性较低。在本研究中,原位逆转录聚合酶链反应首次应用于市售的组织切片微阵列,从而能够同时检测多达70个不同的样本。详细介绍了对该技术的改进,这些改进保留了可见的组织和细胞结构,提高了转录本检测能力,同时防止了大量假象的产生。